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commonly in their fields and defined more detailed grading 
criteria for each complication in accordance with the gen-
eral grading rules of the Clavien-Dindo classification.
Results We listed 72 surgical complications experienced 
commonly in surgical trials, focusing on 17 gastroentero-
logic complications, 13 infectious complications, six tho-
racic complications, and several other complications. The 
grading criteria were defined simply and were optimized 
for surgical complications.
Conclusions The JCOG postoperative complications cri-
teria (JCOG PC criteria) aim to standardize the terms used 
to define adverse events (AEs) and provide detailed grading 
guidelines based on the Clavien-Dindo classification. We 
believe that the JCOG PC criteria will allow for more pre-
cise comparisons of the frequency of postoperative compli-
cations among trials across many different surgical fields.
Keywords JCOG postoperative complications criteria 
(JCOG PC criteria) · Clavien-Dindo classification · 
Postoperative complications
Introduction
The evaluation of postoperative complications in surgi-
cal trials is as important as the assessment of toxicities in 
chemotherapy trials. Prior to the proposal of a therapy-ori-
ented classification scheme, by Clavien PA et al. in 1992 
[1], there were no accepted definitions for the grading of 
surgical complications in clinical practice. This framework 
proposed by Clavien et al. was not used widely, because 
there was no system for the grading of severity of surgical 
complications [2] and no uniform definition of these events. 
For instance, some surgeons included a body tempera-
ture greater than 38 °C on two consecutive days as being 
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“high”, whereas others included intraoperative complica-
tions, postoperative complications (within 30 days), and 
late events such as dumping syndrome. Few randomized 
controlled trials (RCTs) [3] have used this classification 
system, with individual parochial definitions of surgical 
complications being used in most surgical RCTs [4–6].
In cancer clinical trials, adverse events (AEs) are evalu-
ated in accordance with the Common Terminology Criteria 
for Adverse Events (CTCAE), which is far from exhaustive 
in terms of surgical complications; thus, some surgeons are 
not comfortable using grading definitions. The Clavien-
Dindo classification, published in 2004 [7] defined a sim-
ple classification of postoperative complications, which has 
been adopted widely in clinical practice. Although this clas-
sification categorizes postoperative complications broadly 
into four major groups, it is often desirable to more clearly 
define the common AEs to avoid the use of different or less 
precise terms for the same AEs occurring in different clini-
cal trials. More detailed grading criteria for common AEs 
would also be helpful for surgeons. Therefore, our aim was 
to establish supplementary criteria for the Clavien-Dindo 
classification to standardize the evaluation of postoperative 
complications.
Methods
The Japan Clinical Oncology Group (JCOG) commis-
sioned a committee to establish more precise criteria for 
the grading of surgical complications. The committee com-
prised members from nine JCOG study groups (gastric, 
esophageal, colorectal, lung, breast, gynecologic, urologic, 
bone and soft tissue, and brain) who have extensive expe-
rience with surgical trials. These groups established the 
JCOG postoperative complications criteria (JCOG PC cri-
teria). Members identified the postoperative complications 
experienced commonly in their fields and defined detailed 
grades for each complication in accordance with the gen-
eral grading rules of the Clavien-Dindo classification. The 
JCOG PC criteria were reviewed and approved by the 
JCOG Executive Committee and published on the JCOG 
website in October, 2011 (in Japanese) [8].
Results
The JCOG PC criteria included 72 surgical AEs experi-
enced commonly in surgical trials, including 17 gastroen-
terological complications, 13 infectious complications, six 
thoracic complications, and several other complications 
(Table 1). If no applicable AE terms are found in the JCOG 
PC criteria, ‘other (specify)’ should be chosen. In such 
cases, the appropriate AE term should be used, and the 
overall grading should be performed in accordance with the 
general rules of the Clavien-Dindo classification. Because 
the grading definitions follow the general rules of the Cla-
vien-Dindo classification, surgeons can use these original 
rules to grade AEs, and can also refer to the more detailed 
definitions in the JCOG PC criteria if necessary. Table 2 
lists the differences between CTCAE, the Clavien-Dindo 
classification, and the JCOG PC criteria.
Discussion
Until Clavien PA et al. published their original classifica-
tion in 1992, there were no established criteria or frame-
work available to standardize surgical complications in 
surgical trials. In 2003, the US National Cancer Institute-
Common Toxicity Criteria (NCI-CTC) version 2.0 [9] 
were revised and renamed the CTCAE version 3.0 [10]. 
This system has been used widely to evaluate and define 
the toxicity of chemotherapy or radiotherapy. While terms 
and definitions for AEs occurring as a result of intraopera-
tive and postoperative complications were not included in 
the NCI-CTC version 2.0, some surgical AE terms were 
incorporated in the CTCAE version 3.0. Nevertheless, the 
CTCAE version 3.0 failed to include many surgical com-
plications and surgeons were frequently unable to objec-
tively classify complications using its grading definitions.
In 2009, the CTCAE version 4.0 [11] was released, with 
considerably more surgical AE terms, but several common 
surgical complications were still not included. For exam-
ple, intra-abdominal abscess, pyothorax, delayed gastric 
emptying, and lung torsion were not listed as AE terms. 
Moreover, grading definitions were not clinically optimized 
for some surgical AEs. For example, the grading defini-
tion of pancreatic fistula in this version of the CTCAE is 
suitable for pancreatitis, but not for pancreatic fistula after 
pancreatectomy. Such inappropriate definitions have made 
surgeons reluctant to use the CTCAE version 4.0 in surgi-
cal trials.
In 2004, the Clavien-Dindo classification was modified 
to allow for the grading of life-threatening complications 
and long-term disability caused by a complication. This 
revised version defines five grades of severity (Grade I, II, 
IIIa, IIIb, IVa, IVb, and V) and the suffix “d” (for “disabil-
ity”) is used to denote any postoperative impairment [7]. 
This refined Clavien-Dindo classification has been used 
increasingly in clinical practice and also in clinical trials 
involving surgical procedures, because it is simple, repro-
ducible, and flexible [12]. Rather than providing specific 
grading criteria for each AE, the Clavien-Dindo classifica-
tion provides broad-based but general criteria that can be 
used uniformly for all kinds of surgical AEs. However, sev-
eral issues have emerged since this classification became 
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1 3
more widely used. One controversial issue is that AE terms 
are not well defined and different AE terms designate the 
same AEs in different clinical trials. For example, when 
intestinal obstruction occurs, some investigators could 
report this AE as “ileus”, but others refer to it as “small 
bowel obstruction” or “colon obstruction”. Under such 
circumstances, the incidence of this AE cannot be counted 
accurately. A second issue is that only general grading cri-
teria are defined and therefore, grading can be difficult in 
some cases and subject to bias by the grader. For example, 
primary non-operative treatment for intestinal obstruction 
is gastroenteric tube decompression. Nasogastric tube or 
nasoenteric tube is utilized depending on the severity, but 
the original Clavien-Dindo classification does not define 
what grading should be applied for any type of gastroen-
teric tube placement for decompression.
The JCOG PC criteria were established to address these 
issues. The advantages of the JCOG PC criteria are as fol-
lows: First, commonly experienced surgical AEs are speci-
fied and listed. To compare precisely the frequency of surgi-
cal complications between studies, use of the common AE 
terms specified in the JCOG PC criteria is recommended. 
Second, grading definitions are straightforward and opti-
mized for surgical complications. With these advantages, 
the JCOG recommends that the JCOG PC criteria be used 
to supplement the Clavien-Dindo classification, while 
maintaining the overall Clavien-Dindo classification. In 
JCOG, some disease-oriented subgroups are conducting 
clinical trials including surgery and using both the CTCAE 
and JCOG PC criteria to evaluate postoperative compli-
cations. After these trials are completed, we will evaluate 
the concordance between the grading by the CTCAE and 
that by the JCOG PC criteria. We also plan to explore the 
advantages and disadvantages of the JCOG PC criteria.
The JCOG PC criteria have some limitations. First, these 
AE terms were chosen somewhat arbitrarily, but by experi-
enced surgeons, and specific grading was decided based on 
the opinions and experience of our committee members. A 
second limitation of the JCOG PC criteria is that they do 
not include intraoperative complications. Our intent was to 
further define and clarify the criteria of the Clavien-Dindo 
classification and we considered that incorporating intra-
operative complications would deviate too much from the 
original concept. Another common classification may be 
required to define and grade intraoperative complications. 
A third limitation is that all descriptions in the Clavien-
Dindo classification pertain to early postoperative com-
plications. Here, ‘early postoperative’ generally indicates 
the time from surgery to the first hospital discharge, but 
in theory, the Clavien-Dindo classification can be applied 
broadly to late postoperative complications after hospital 
discharge. Within this context, the JCOG PC criteria are 
mainly intended to be used for early postoperative compli-
cations, but they can also be used after hospital discharge, 
although would require more definitions and AEs.
In conclusion, the goals of the JCOG PC criteria are to 
standardize the AE terms used for early postoperative com-
plications by providing more detailed grading guidelines 
based on the Clavien-Dindo classification. We suggest that 
researchers use the JCOG PC criteria in every surgical trial 
to allow for precise comparison of the frequency of surgical 
complications among trials.
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